about
The role of Cdk5 in neuroendocrine thyroid cancerRET gene abnormalities and thyroid disease: who should be screened and whenNodular Graves' disease with medullary thyroid cancer.Medullary thyroid carcinoma: targeted therapies and future directionsNotch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.Pregnancy and thyroid cancer: ultrasound study of foetal thyroid.Multi-targeted approach in the treatment of thyroid cancer.Utility of a PI3K/mTOR inhibitor (NVP-BEZ235) for thyroid cancer therapy.Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer.Molecular profiling of thyroid cancer subtypes using large-scale text mining.A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma.Expression of the active Notch1 decreases MTC tumor growth in vivo.Nuclear Medicine in Thyroid Diseases in Pediatric and Adolescent Patients.Medullary thyroid carcinoma: The third most common thyroid cancer reviewedThe North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancerRecurrent spinal metastasis of a sporadic medullary carcinoma of the thyroid after radiation therapy: a case report and review of the literature.Hereditary medullary thyroid cancer: age-appropriate thyroidectomy improves disease-free survival.Pediatric Medullary Thyroid CarcinomaFrom preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial.Glucagon-Like Peptide-1 Receptor Imaging with [Lys (40) (Ahx-HYNIC- (99 m) Tc/EDDA)NH 2 ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report.Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma.Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer HospitalTautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.New developments in the diagnosis and treatment of thyroid cancer.Current understanding and management of medullary thyroid cancer.Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysis.Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapy.Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.Oncocytic Variant of Medullary Thyroid Carcinoma: A Rare Case of Sporadic Multifocal and Bilateral RET Wild-Type Neoplasm with Revision of the LiteratureDifferences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.Vandetanib: in medullary thyroid cancer.Vandetanib: a guide to its use in advanced medullary thyroid cancer.Surgical approach to the management of medullary thyroid cancer: when is lymph node dissection needed?A role for radiotherapy in the management of advanced medullary thyroid carcinoma: the mayo clinic experience.MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases.
P2860
Q28392185-9B3EA55C-295B-4B66-AE00-3909BE458CE1Q28709562-2A7133F4-2493-4B5F-A484-403A19D5C53DQ30401864-289F4399-8206-43F0-9945-9206AFC76D5FQ33557376-DC1658D0-651F-4FAF-8428-BE537597BD60Q33680709-78FB3248-111F-45B5-81DB-45D5CEAED605Q33804934-92C4EFA2-0D6A-453A-898A-4CABD37AC6AFQ33844128-3A3B6065-DD4E-4711-81D6-2A69481AAEB8Q33982413-F32D7337-928A-4457-A692-55FD358F1C55Q34450398-BD9DD298-4B13-4E67-9F37-A5989E224857Q34617707-46C4FD3A-C08A-47F7-990E-F555E7C3E02EQ34914970-682EDE3A-DA33-481E-B8E4-580B47BBCB28Q35064499-306850D4-6294-4113-99C3-BAB42726AF18Q35098936-BE3F60F0-DC83-4457-824A-648BBFCB1BE8Q35169079-0D8F74D9-5A88-42DD-822E-A229D745B9F1Q36038769-194BC736-92C9-4EAC-99B7-6CB6F00AC0B8Q36142421-4CB945AD-6DC5-41D5-9536-5E658E2DCDBCQ36164034-289C4808-6E6A-45EB-92BB-88F1A9602FA5Q36445431-3AF53441-A6BA-4035-B60D-745BB153F682Q36652843-059EAF64-418C-402C-8946-B62C4AFDED33Q36715586-36BC3EFA-B8FC-400D-9F97-5C826BDDBDE0Q36755148-C37A4339-6B74-49AA-9651-7B957F1EC06BQ36765871-58204B8B-6B95-4905-9706-9EF47104B9F6Q37009001-4746F606-2E80-4587-9BC4-4381E17919CAQ37011949-C7F9A62B-A2DC-4462-8007-3CF1F9394317Q37161813-ED3CC27A-73E1-44FE-B82E-12DCD79D7735Q37238757-1B3F7F7C-EBCB-4E32-B1A5-81E65E0625BCQ37247181-DF5341AA-996F-4FBD-B0EF-C0F6662063EAQ37332674-9774C0A6-3D8B-4EB2-AAD6-5C1BF6CC6880Q37402609-3C8FE20F-BA8B-4858-AC25-15C274ED4D26Q37403020-FF28AC68-B780-4641-BA61-D8597F04D24EQ37431034-309588A9-D1FF-41BF-B411-F1F70F98E2EAQ37579719-85C71BBF-8ACA-40FF-B799-52278ECBB1EEQ37633558-021DC115-DA6E-4FCB-BC51-23FEA24D9434Q37985518-191E5ACD-7AA9-411F-BBF6-430AE7B51EF7Q38020194-FE89256A-2A97-4703-9EFC-19D123C3B9FAQ38039483-FDDF6EF5-07AB-49D7-B570-9E04F4579E11Q38108096-4CA8A8C7-66B8-40DD-93D8-19B0B4637734Q38157948-DE34F2D4-ECBB-49EA-968B-771E3E3F444AQ38287178-4E2AFC4D-630E-42AA-8B4D-0263198A4F4EQ38683133-837CE850-FD72-4C7B-B6EE-0A7591900806
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Current management of medullary thyroid cancer.
@en
type
label
Current management of medullary thyroid cancer.
@en
prefLabel
Current management of medullary thyroid cancer.
@en
P2093
P1433
P1476
Current management of medullary thyroid cancer.
@en
P2093
Herbert Chen
Muthusamy Kunnimalaiyaan
Rebecca S Sippel
P304
P356
10.1634/THEONCOLOGIST.2007-0239
P577
2008-05-01T00:00:00Z